UN Drug control system
Weaknesses in the UN drug control system have often been identified, related to the functioning of the key organs UNODC, INCB, and the CND; related to collaboration with the wider UN system (WHO, UNAIDS, UNDP, etc.) and related to the outdated character of several treaty provisions. What has been attempted to date to achieve more structural reform? Are existing evaluation mechanisms capable of bringing the need for reform to the table? How could a neutral and evidence-based role of UNODC as a centre of expertise be strengthened? How can these issues be related to the UN call for more ‘system-wide coherence’ and ‘delivery as one’?
March 2012
Dave Bewley-Taylor
Series on Legislative Reform of Drug Policies Nr. 19
March 2012
Dave Bewley-Taylor
Series on Legislative Reform of Drug Policies Nr. 18
June 2011
Subscribe
Upcoming events
-
Het vrijhandelsverdrag met Colombia
May 2012
Amsterdam, Netherlands
-
EU crisis: Another way is possible
June 2012
Amsterdam, Netherlands
-
Global Land Grabbing Colloquium
June 2012
Den Haag, Netherlands
-
Hoe schoon is gas?
June 2012
Amsterdam, Netherlands















